Cash flow Colgate-Palmolive Company

Stocks

CL

US1941621039

Personal Products

Market Closed - NYSE Other stock markets 00:00:02 21/07/2026 +04			5-day change	1st Jan Change
91.93 ^USD	-1.13%		-1.37%	+16.34%

07-16	Consumer Staple Companies Likely Saw Another 'Tricky' Quarter, UBS Says	MT
07-16	UBS Adjusts Price Target on Colgate-Palmolive to $106 From $100, Maintains Buy Rating	MT

879.AiGwVDfqkTCbsmGDVijqGq-H_CSwvI_XbwOj_xpcAqc.U03AYX6IpFXji1XuN0GdU_2wyUf03eizGVrIrFgRcfE6b_M_cajeXfbIIA

Published financial data: COLGATE-PALMOLIVE COMPANY

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: December	2021	2022	2023	2024	2025
Revenues	17.42B	17.97B	19.46B	20.1B	20.38B
Total Revenues	17.42B	17.97B	19.46B	20.1B	20.38B
Cost of Goods Sold, Total	7.05B	7.72B	8.13B	7.92B	8.13B
Gross Profit	10.38B	10.25B	11.33B	12.18B	12.25B
Selling General & Admin Expenses, Total	6.48B	6.62B	7.24B	7.81B	7.89B
Other Operating Expenses	67M	19M	148M	121M	126M
Other Operating Expenses, Total	6.54B	6.64B	7.38B	7.93B	8.01B
Operating Income	3.83B	3.6B	3.94B	4.25B	4.24B
Interest Expense, Total	-192M	-167M	-287M	-292M	-267M
Interest And Investment Income	17M	14M	55M	67M	75M
Net Interest Expenses	-175M	-153M	-232M	-225M	-192M
Income (Loss) On Equity Invest.	12M	12M	17M	22M	20M
Currency Exchange Gains (Loss)	-	-	-	-	-
EBT, Excl. Unusual Items	3.67B	3.46B	3.73B	4.05B	4.07B
Restructuring Charges	-	-110M	-32M	-85M	-13M
Merger & Related Restructuring Charges	-	-19M	-	-	-9M
Impairment of Goodwill	-367M	-332M	-	-	-582M
Gain (Loss) On Sale Of Investments	-10M	-	-11M	-6M	-1M
Gain (Loss) On Sale Of Assets	-	47M	-	-	-
Asset Writedown	-204M	-389M	-	-	-337M
Legal Settlements	-	-	-267M	-	-65M
Other Unusual Items	-	-	-25M	-	-
EBT, Incl. Unusual Items	3.09B	2.66B	3.39B	3.96B	3.06B
Income Tax Expense	749M	693M	937M	907M	798M
Earnings From Continuing Operations	2.34B	1.97B	2.46B	3.05B	2.26B
Net Income to Company	2.34B	1.97B	2.46B	3.05B	2.26B
Minority Interest	-172M	-182M	-155M	-160M	-129M
Net Income - (IS)	2.17B	1.78B	2.3B	2.89B	2.13B
Net Income to Common Incl Extra Items	2.17B	1.78B	2.3B	2.89B	2.13B
Net Income to Common Excl. Extra Items	2.17B	1.78B	2.3B	2.89B	2.13B
Per Share Items
Net EPS - Basic	2.56	2.13	2.78	3.53	2.64
Basic EPS - Continuing Operations	2.56	2.13	2.78	3.53	2.64
Basic Weighted Average Shares Outstanding	845M	836M	827M	819M	809M
Net EPS - Diluted	2.55	2.13	2.77	3.51	2.63
Diluted EPS - Continuing Operations	2.55	2.13	2.77	3.51	2.63
Diluted Weighted Average Shares Outstanding	848M	839M	829M	823M	811M
Normalized Basic EPS	2.51	2.37	2.63	2.89	2.98
Normalized Diluted EPS	2.5	2.36	2.62	2.88	2.97
Dividend Per Share	1.79	1.86	1.91	1.98	2.06
Payout Ratio	77.52	94.73	76.04	61.92	85.51
American Depositary Receipts Ratio (ADR)	0.14	0.14	0.14	0.14	0.14
Supplemental Items
EBITDA	4.39B	4.15B	4.51B	4.86B	4.87B
EBITA	3.92B	3.68B	4.01B	4.32B	4.32B
EBIT	3.83B	3.6B	3.94B	4.25B	4.24B
EBITDAR	4.56B	4.31B	4.67B	5.02B	5.04B
Effective Tax Rate - (Ratio)	24.26	26.05	27.62	22.93	26.09
Normalized Net Income	2.12B	1.98B	2.17B	2.37B	2.41B
Interest Capitalized	3M	5M	12M	-	-
Non-Cash Pension Expense	12M	34M	341M	68M	33M
Supplemental Operating Expense Items
Advertising Expense	2.02B	2B	2.37B	2.72B	2.7B
Selling and Marketing Expenses	2.02B	2B	2.37B	2.72B	2.7B
Research And Development Expense From Footnotes	307M	320M	343M	355M	366M
Net Rental Expense, Total	168M	160M	157M	164M	169M
Imputed Operating Lease Interest Expense	32.62M	25.71M	40.96M	43.59M	42.3M
Imputed Operating Lease Depreciation	135M	134M	116M	120M	127M
Stock-Based Comp., SG&A Exp. (Total)	135M	125M	122M	135M	155M
Total Stock-Based Compensation	135M	125M	122M	135M	155M

Fiscal Period: December	2021	2022	2023	2024	2025
Assets
Cash And Equivalents	832M	775M	966M	1.1B	1.29B
Short Term Investments	34M	175M	179M	160M	107M
Trading Asset Securities, Total	5M	-	-	-	-
Total Cash And Short Term Investments	871M	950M	1.14B	1.26B	1.4B
Accounts Receivable, Total	1.3B	1.5B	1.59B	1.52B	1.68B
Total Receivables	1.3B	1.5B	1.59B	1.52B	1.68B
Inventory	1.69B	2.07B	1.93B	1.99B	2.03B
Prepaid Expenses	-	-	-	520M	589M
Other Current Assets, Total	537M	585M	614M	33M	18M
Total Current Assets	4.4B	5.11B	5.28B	5.32B	5.71B
Gross Property Plant And Equipment	9.43B	10.06B	10.78B	10.66B	11.39B
Accumulated Depreciation	-5.17B	-5.28B	-5.7B	-5.7B	-6.2B
Net Property Plant And Equipment	4.26B	4.78B	5.07B	4.95B	5.19B
Long-term Investments	84M	-	83M	81M	82M
Goodwill	3.28B	3.35B	3.41B	3.27B	3.12B
Other Intangibles, Total	2.46B	1.92B	1.89B	1.76B	1.54B
Deferred Tax Assets Long-Term	193M	135M	214M	195M	205M
Other Long-Term Assets, Total	363M	426M	447M	474M	485M
Total Assets	15.04B	15.73B	16.39B	16.05B	16.33B
Liabilities
Accounts Payable, Total	1.48B	1.55B	1.7B	1.8B	2.09B
Accrued Expenses, Total	1.94B	1.95B	2.24B	2.34B	2.68B
Short-term Borrowings	39M	11M	310M	8M	2M
Current Portion of Long-Term Debt	12M	14M	20M	652M	1.12B
Current Portion of Leases	137M	108M	95M	107M	118M
Current Income Taxes Payable	436M	317M	336M	403M	383M
Other Current Liabilities	13M	54M	37M	446M	471M
Total Current Liabilities	4.05B	4B	4.74B	5.76B	6.85B
Long-Term Debt	7.17B	8.7B	8.17B	7.23B	6.8B
Long-Term Leases	495M	441M	473M	515M	520M
Pension & Other Post Retirement Benefits	1.72B	1.13B	1.39B	1.31B	1.24B
Deferred Tax Liability Non Current	395M	383M	361M	343M	181M
Other Non Current Liabilities	235M	271M	305M	349M	371M
Total Liabilities	14.07B	14.92B	15.44B	15.5B	15.96B
Common Stock, Total	1.47B	1.47B	1.47B	1.47B	1.47B
Additional Paid In Capital	3.27B	3.55B	3.81B	4.18B	4.32B
Retained Earnings	24.35B	24.57B	25.29B	26.14B	26.6B
Treasury Stock	-24.09B	-25.13B	-26.02B	-27.36B	-28.45B
Comprehensive Income and Other	-4.39B	-4.06B	-3.94B	-4.22B	-3.88B
Total Common Equity	609M	401M	609M	212M	54M
Minority Interest	362M	405M	348M	332M	311M
Total Equity	971M	806M	957M	544M	365M
Total Liabilities And Equity	15.04B	15.73B	16.39B	16.05B	16.33B
Supplemental Items
ECS Total Shares Outstanding on Filing Date	840M	830M	823M	812M	802M
ECS Total Common Shares Outstanding	840M	830M	821M	813M	801M
Book Value / Share	0.72	0.48	0.74	0.26	0.07
Tangible Book Value	-5.14B	-4.87B	-4.69B	-4.82B	-4.6B
Tangible Book Value Per Share	-6.11	-5.87	-5.71	-5.93	-5.75
Total Debt	7.85B	9.27B	9.06B	8.51B	8.55B
Net Debt	6.98B	8.32B	7.92B	7.26B	7.16B
Debt Equivalent of Unfunded Proj. Benefit Obligation	587M	469M	772M	719M	620M
Debt Equivalent Oper. Leases	1.34B	1.28B	1.26B	1.31B	1.35B
Minority Interest, Total (Incl. Fin. Div)	362M	405M	348M	332M	311M
Equity Method Investments, Total	64M	-	83M	81M	82M
Account Code - Inventory Valuation	5	5	5	5	5
LIFO Reserve, Total	-60M	-146M	-120M	-105M	-129M
Inventories - Raw Materials, Total	-	-	-	-	-
Inventories - Work In Process, Total	-	-	-	-	-
Inventories - Finished Goods, Total	-	-	-	-	-
Land - (BS)	163M	180M	227M	226M	234M
Buildings, Total	1.6B	1.82B	2.05B	2.06B	2.17B
Machinery, Total	7.13B	7.58B	8.01B	7.84B	8.45B
Full Time Employees	33.8K	33.8K	34K	34K	33.6K
Accumulated Allowance for Doubtful Accounts (Supple)	78M	70M	80M	85M	90M

Fiscal Period: December	2021	2022	2023	2024	2025
Net Income	2.17B	1.78B	2.3B	2.89B	2.13B
Depreciation & Amortization - CF	467M	465M	495M	530M	552M
Amortization of Goodwill and Intangible Assets - (CF)	89M	80M	72M	75M	78M
Depreciation & Amortization, Total	556M	545M	567M	605M	630M
(Gain) Loss From Sale Of Asset	-	-47M	-	-	-
Asset Writedown & Restructuring Costs	550M	770M	-23M	51M	912M
Stock-Based Compensation (CF)	135M	125M	122M	135M	155M
Other Operating Activities, Total	115M	104M	324M	83M	85M
Change In Accounts Receivable	-84M	-227M	-37M	-56M	-16M
Change In Inventories	-72M	-333M	194M	-100M	109M
Change In Accounts Payable	14M	-115M	309M	516M	251M
Change in Other Net Operating Assets	-55M	-51M	-11M	-16M	-60M
Cash from Operations	3.32B	2.56B	3.74B	4.11B	4.2B
Capital Expenditure	-567M	-696M	-705M	-561M	-564M
Sale of Property, Plant, and Equipment	-	-	-	-	-
Cash Acquisitions	-	-809M	-	-	-293M
Sale (Purchase) of Real Estate properties	-	47M	-	-	-
Investment in Marketable and Equity Securities, Total	0	-148M	-4M	-10M	54M
Other Investing Activities, Total	-25M	5M	-33M	37M	-14M
Cash from Investing	-592M	-1.6B	-742M	-534M	-817M
Short Term Debt Issued, Total	-	540M	-	93M	-
Long-Term Debt Issued, Total	699M	1.51B	1.5B	2M	1.19B
Total Debt Issued	699M	2.05B	1.5B	95M	1.19B
Short Term Debt Repaid, Total	-171M	-	-906M	-	-989M
Long-Term Debt Repaid, Total	-628M	-406M	-903M	-503M	-655M
Total Debt Repaid	-799M	-406M	-1.81B	-503M	-1.64B
Issuance of Common Stock	424M	418M	380M	638M	101M
Repurchase of Common Stock	-1.32B	-1.31B	-1.13B	-1.74B	-1.21B
Common Dividends Paid	-1.68B	-1.69B	-1.75B	-1.79B	-1.82B
Common & Preferred Stock Dividends Paid	-1.68B	-1.69B	-1.75B	-1.79B	-1.82B
Other Financing Activities, Total	-99M	-18M	18M	-91M	132M
Cash from Financing	-2.77B	-952M	-2.79B	-3.39B	-3.26B
Foreign Exchange Rate Adjustments	-15M	-60M	-19M	-54M	67M
Net Change in Cash	-56M	-57M	191M	130M	192M
Supplemental Items
Cash Interest Paid	194M	151M	280M	302M	270M
Cash Income Tax Paid (Refund)	890M	945M	937M	933M	913M
Levered Free Cash Flow	2.15B	1.49B	2.74B	3.4B	3.08B
Unlevered Free Cash Flow	2.27B	1.6B	2.92B	3.58B	3.24B
Change In Net Working Capital	250M	629M	-474M	-749M	-373M
Net Debt Issued / Repaid	-100M	1.65B	-314M	-408M	-456M

Fiscal Period: December	2021	2022	2023	2024	2025
Profitability
Return on Assets	15.47	14.64	15.34	16.38	16.36
Return on Total Capital	26.4	23.83	24.52	27.85	29.47
Return On Equity %	225.68	221.38	278.5	406.26	497.47
Return on Common Equity	320.41	353.47	455.45	703.78	1.6K
Margin Analysis
Gross Profit Margin %	59.55	57.04	58.22	60.6	60.11
SG&A Margin	37.18	36.87	37.19	38.85	38.7
EBITDA Margin %	25.18	23.09	23.17	24.15	23.88
EBITA Margin %	22.5	20.5	20.63	21.52	21.18
EBIT Margin %	21.99	20.06	20.26	21.14	20.79
Income From Continuing Operations Margin %	13.42	10.95	12.62	15.17	11.09
Net Income Margin %	12.43	9.93	11.82	14.37	10.46
Net Avail. For Common Margin %	12.43	9.93	11.82	14.37	10.46
Normalized Net Income Margin	12.17	11.03	11.18	11.79	11.84
Levered Free Cash Flow Margin	12.33	8.31	14.09	16.92	15.09
Unlevered Free Cash Flow Margin	13.02	8.89	15.02	17.83	15.91
Asset Turnover
Asset Turnover	1.13	1.17	1.21	1.24	1.26
Fixed Assets Turnover	4.1	3.97	3.95	4.01	4.02
Receivables Turnover (Average Receivables)	13.6	12.83	12.59	12.94	12.75
Inventory Turnover (Average Inventory)	4.19	4.1	4.06	4.04	4.05
Short Term Liquidity
Current Ratio	1.09	1.28	1.11	0.92	0.83
Quick Ratio	0.54	0.61	0.58	0.48	0.45
Operating Cash Flow to Current Liabilities	0.82	0.64	0.79	0.71	0.61
Days Sales Outstanding (Average Receivables)	26.83	28.45	28.98	28.29	28.62
Days Outstanding Inventory (Average Inventory)	87.16	89.04	89.97	90.6	90.21
Average Days Payable Outstanding	74.19	68.26	74.21	80.4	86.92
Cash Conversion Cycle (Average Days)	39.8	49.23	44.74	38.48	31.9
Long Term Solvency
Total Debt/Equity	808.86	1.15K	947.13	1.56K	2.34K
Total Debt / Total Capital	89	92	90.45	93.99	95.91
LT Debt/Equity	789.5	1.13K	902.72	1.42K	2.01K
Long-Term Debt / Total Capital	86.87	90.68	86.21	85.52	82.06
Total Liabilities / Total Assets	93.54	94.88	94.16	96.61	97.76
EBIT / Interest Expense	19.95	21.58	13.74	14.55	15.87
EBITDA / Interest Expense	23.72	25.8	16.26	17.19	18.87
(EBITDA - Capex) / Interest Expense	20.77	21.63	13.8	15.27	16.75
Total Debt / EBITDA	1.72	2.15	1.94	1.7	1.7
Net Debt / EBITDA	1.53	1.93	1.7	1.45	1.42
Total Debt / (EBITDA - Capex)	1.97	2.57	2.29	1.91	1.91
Net Debt / (EBITDA - Capex)	1.75	2.3	2	1.63	1.6
Growth Over Prior Year
Total Revenues, 1 Yr. Growth %	5.77	3.13	8.29	3.31	1.4
Gross Profit, 1 Yr. Growth %	3.53	-1.22	10.53	7.54	0.57
EBITDA, 1 Yr. Growth %	1.36	-5.21	9.26	7.67	0.27
EBITA, 1 Yr. Growth %	1.11	-5.78	9.61	7.75	-0.21
EBIT, 1 Yr. Growth %	1.11	-5.68	10.05	7.81	-0.28
Earnings From Cont. Operations, 1 Yr. Growth %	-18.25	-15.87	24.81	24.2	-25.84
Net Income, 1 Yr. Growth %	-19.63	-17.59	28.85	25.61	-26.2
Normalized Net Income, 1 Yr. Growth %	0.59	-8.27	10.45	8.97	1.81
Diluted EPS Before Extra, 1 Yr. Growth %	-18.79	-16.47	30.05	26.71	-25.07
Accounts Receivable, 1 Yr. Growth %	2.61	15.96	5.45	-4.1	10.12
Inventory, 1 Yr. Growth %	1.14	22.58	-6.75	2.74	2.26
Net Property, Plant and Equip., 1 Yr. Growth %	0.47	12.4	6.02	-2.4	4.85
Total Assets, 1 Yr. Growth %	-5.53	4.59	4.21	-2.12	1.77
Tangible Book Value, 1 Yr. Growth %	-14.03	-5.18	-3.76	2.73	-4.4
Common Equity, 1 Yr. Growth %	-18.04	-34.15	51.87	-65.19	-74.53
Cash From Operations, 1 Yr. Growth %	-10.59	-23.13	46.52	9.67	2.22
Capital Expenditures, 1 Yr. Growth %	38.29	22.75	1.29	-20.43	0.53
Levered Free Cash Flow, 1 Yr. Growth %	-27.68	-31.79	85.37	24.04	-9.58
Unlevered Free Cash Flow, 1 Yr. Growth %	-26.47	-29.38	84.48	22.67	-9.53
Dividend Per Share, 1 Yr. Growth %	2.29	3.91	2.69	3.66	4.04
Compound Annual Growth Rate Over Two Years
Total Revenues, 2 Yr. CAGR %	5.36	4.44	5.68	5.77	2.35
Gross Profit, 2 Yr. CAGR %	5.42	1.15	4.49	9.02	4
EBITDA, 2 Yr. CAGR %	2.66	-2.08	1.59	8.73	4
EBITA, 2 Yr. CAGR %	2.85	-1.38	1.42	8.97	3.8
EBIT, 2 Yr. CAGR %	2.53	-2.46	1.68	9.23	3.79
Earnings From Cont. Operations, 2 Yr. CAGR %	-3.81	-17.07	2.47	24.5	-4.03
Net Income, 2 Yr. CAGR %	-4.34	-18.62	3.05	27.22	-3.72
Normalized Net Income, 2 Yr. CAGR %	2.14	-3.01	0.42	10.06	5.45
Diluted EPS Before Extra, 2 Yr. CAGR %	-3.7	-17.64	4.22	28.37	-2.56
Accounts Receivable, 2 Yr. CAGR %	-5.1	9.08	10.58	0.56	2.77
Inventory, 2 Yr. CAGR %	9.94	11.34	6.91	-2.12	2.5
Net Property, Plant and Equip., 2 Yr. CAGR %	0.06	6.27	9.16	1.72	1.16
Total Assets, 2 Yr. CAGR %	0.02	-0.6	4.4	1	-0.19
Tangible Book Value, 2 Yr. CAGR %	-7.91	-9.71	-4.47	-0.57	-0.9
Common Equity, 2 Yr. CAGR %	128.15	-26.54	0	-27.29	-70.22
Cash From Operations, 2 Yr. CAGR %	3.02	-17.1	6.13	26.76	5.88
Capital Expenditures, 2 Yr. CAGR %	30.1	30.29	11.51	-10.22	-10.56
Levered Free Cash Flow, 2 Yr. CAGR %	-2.85	-29.1	12.06	52.28	6
Unlevered Free Cash Flow, 2 Yr. CAGR %	-2.71	-28.03	13.77	51.03	5.44
Dividend Per Share, 2 Yr. CAGR %	2.31	3.1	3.3	3.18	3.85
Compound Annual Growth Rate Over Three Years
Total Revenues, 3 Yr. CAGR %	3.87	4.61	5.71	4.89	4.29
Gross Profit, 3 Yr. CAGR %	3.86	3.16	4.18	5.49	6.13
EBITDA, 3 Yr. CAGR %	0.92	-0.11	1.38	3.58	5.83
EBITA, 3 Yr. CAGR %	0.88	-0.2	1.95	3.49	5.82
EBIT, 3 Yr. CAGR %	0.63	-0.37	1.34	3.68	5.96
Earnings From Cont. Operations, 3 Yr. CAGR %	-2.95	-8.01	-4.96	9.25	4.75
Net Income, 3 Yr. CAGR %	-3.36	-8.98	-5.15	10.08	6.1
Normalized Net Income, 3 Yr. CAGR %	0.19	-0.83	1.05	3.19	7.24
Diluted EPS Before Extra, 3 Yr. CAGR %	-2.49	-8.16	-4.09	11.24	7.28
Accounts Receivable, 3 Yr. CAGR %	-2.52	1.46	7.86	5.45	3.65
Inventory, 3 Yr. CAGR %	10.62	14	4.95	5.5	-0.68
Net Property, Plant and Equip., 3 Yr. CAGR %	3.13	4.02	6.19	5.16	2.75
Total Assets, 3 Yr. CAGR %	7.34	1.52	0.98	2.18	1.25
Tangible Book Value, 3 Yr. CAGR %	6.36	-7.01	-7.77	-2.13	-1.86
Common Equity, 3 Yr. CAGR %	81.41	50.77	-6.41	-29.65	-48.74
Cash From Operations, 3 Yr. CAGR %	2.85	-6.56	0.23	7.29	17.99
Capital Expenditures, 3 Yr. CAGR %	9.15	27.6	19.8	-0.35	-6.77
Levered Free Cash Flow, 3 Yr. CAGR %	-3.28	-13.12	-2.62	15.92	27.99
Unlevered Free Cash Flow, 3 Yr. CAGR %	-3.13	-12.64	-1.79	16.67	27.32
Dividend Per Share, 3 Yr. CAGR %	2.55	2.84	2.96	3.42	3.46
Compound Annual Growth Rate Over Five Years
Total Revenues, 5 Yr. CAGR %	2.77	3.06	4.59	5.08	4.35
Gross Profit, 5 Yr. CAGR %	2.5	1.84	4.11	5.46	4.11
EBITDA, 5 Yr. CAGR %	-0.1	-1.12	1.1	3.12	2.38
EBITA, 5 Yr. CAGR %	-0.44	-1.43	1.01	3.14	2.64
EBIT, 5 Yr. CAGR %	-0.74	-1.69	0.96	3.12	2.27
Earnings From Cont. Operations, 5 Yr. CAGR %	-2	-1.98	-0.82	3.83	-4.59
Net Income, 5 Yr. CAGR %	-2.36	-2.48	-0.85	4.07	-4.58
Normalized Net Income, 5 Yr. CAGR %	-1.47	-2.47	0.62	3.11	2.74
Diluted EPS Before Extra, 5 Yr. CAGR %	-1.28	-1.35	0.14	5	-3.48
Accounts Receivable, 5 Yr. CAGR %	-1.67	0.32	2.53	1.1	5.79
Inventory, 5 Yr. CAGR %	7.64	11.18	9.12	7.25	3.96
Net Property, Plant and Equip., 5 Yr. CAGR %	2.08	3.28	5.5	3.09	4.14
Total Assets, 5 Yr. CAGR %	4.41	4.41	6.15	1.31	0.51
Tangible Book Value, 5 Yr. CAGR %	7	6.12	1.89	-4.49	-5.08
Common Equity, 5 Yr. CAGR %	20.17	46.22	42.96	12.62	-40.81
Cash From Operations, 5 Yr. CAGR %	1.15	-3.5	4.15	5.56	2.45
Capital Expenditures, 5 Yr. CAGR %	-0.89	4.71	10.09	10.86	6.59
Levered Free Cash Flow, 5 Yr. CAGR %	-4.95	-9.13	2.92	8.36	0.7
Unlevered Free Cash Flow, 5 Yr. CAGR %	-4.55	-8.61	3.21	8.38	1.01
Dividend Per Share, 5 Yr. CAGR %	2.92	3.19	2.85	2.98	3.32